- Online only
10CFU® Mycoplasma Standards are inactivated, non-infectious, lyophilized mycoplasma particles designed as reference material for product-specific validation of PCR-based mycoplasma testing methods.
- Compliant with EP 2.6.7 (12.2), USP <77>, and JP 18 G3
- Defined concentration of ≤10 CFU/ml, GC:CFU ratio <10
- Suitable for product-specific validation and for use as EPC/EIC
Cat. no.: 105-1101
Validation Guide for 10CFU® Mycoplasma salivarium
Please use this form to request a validation guide.
All fields are required. Please use your business contact data.
Please provide your first name. Please provide your last name. The e-mail seems to be missing or incorrect. Please provide your company/institution. Send Validation GuideMycoplasma contamination represents one of the most critical risks in cell culture systems and biopharmaceutical manufacturing, including ATMPs. The European Pharmacopoeia (EP) 2.6.7, the United States Pharmacopeia (USP) <77>, and the Japanese Pharmacopoeia (JP) 18 G3 require validated test methods capable of detecting both cultivable and non-cultivable mycoplasma.
10CFU® Mycoplasma Standards were specifically developed to meet these regulatory requirements. Manufactured in accordance with EP 2.6.7 (edition 12.2), the standards are non-infectious and safe to handle. After reconstitution, defined quantities of the standard are spiked into the respective product or sample matrix to enable Limit of Detection (LOD) determination and use as an External Positive Control (EPC) with a defined concentration.
Mycoplasma salivarium is a human-associated mycoplasma species and part of the normal oral microbiota. It may occur as a contaminant in human cell culture systems. The 10CFU® Mycoplasma salivarium standard is therefore particularly suitable for risk-based validation of NAT-based mycoplasma testing in human cell culture and biopharmaceutical manufacturing processes.
| Product category | 10CFU® Mycoplasma Standards |
|---|---|
| Species | Mycoplasma salivarium (Metamycoplasma salivarium) |
| Sample type | Inactivated mycoplasma particles (DNA/RNA-containing) |
| NCTC code | 10113 |
| ATCC code | 23064 |
| Application | NAT-based mycoplasma testing |
| Application areas |
|
| Regulatory compliance | EP 2.6.7 (12.2), USP <77>, JP 18 G3 |
| Contents |
|
| Detection method |
|
| Required equipment & consumables |
|
| Concentration | ≤10 CFU/ml |
| Storage | 2-8 °C |
| Shipping | Ambient temperature |
| Shelf life | See package labeling |
Cat. No. 105-1001: Mycoplasma arginini
Cat. No. 105-2001: Mycoplasma orale
Cat. No. 105-3001: Mycoplasma gallisepticum
Cat. No. 105-4001: Mycoplasma pneumoniae
Cat. No. 105-5001: Mycoplasma synoviae
Cat. No. 105-6001: Mycoplasma fermentans
Cat. No. 105-7001: Mycoplasma hyorhinis
Cat. No. 105-8001: Acholeplasma laidlawii
Cat. No. 105-9001: Spiroplasma citri